Machine Learning-Based Prediction of Three-Year Heart Failure and Mortality After Premature Ventricular Contraction

Chung-Yu Lin1,2, Yu-Te Lai3, Chien-Wei Chuang1

  • 1Graduate Institute of Business Administration, Fu Jen Catholic University, New Taipei City 242062, Taiwan.

PubMed

Insights

Predicting long-term heart failure and mortality after premature ventricular contraction (PVC) ablation is crucial. Machine learning models, particularly LightGBM with ROSE, show promise in risk stratification, aiding clinical decision-making.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Machine Learning

Background:

  • Long-term outcomes, including heart failure and mortality, following catheter ablation for premature ventricular contractions (PVCs) are not well understood.
  • Effective risk stratification models are needed to identify patients at higher risk for adverse events post-ablation.

Purpose of the Study:

  • To develop and compare machine learning models for predicting three-year heart failure and mortality after PVC ablation.
  • To assess the performance of different algorithms in handling class imbalance in predicting rare events.

Main Methods:

  • Retrospective analysis of 4195 adult patients undergoing PVC ablation using a nationwide claims database.
  • Application of synthetic minority over-sampling technique (SMOTE) and random over-sampling examples (ROSE) to address class imbalance.
  • Comparison of logistic regression, decision tree, random forest, XGBoost, and LightGBM, evaluated using ROC AUC and PR curves.

Main Results:

  • LightGBM with ROSE achieved the highest ROC AUC (0.822) for predicting three-year heart failure.
  • Logistic regression and LightGBM with ROSE demonstrated comparable performance (ROC AUCs 0.886 and 0.882) for three-year mortality prediction.
  • Key predictors identified include age, prior heart failure, malignancy, and end-stage renal disease.

Conclusions:

  • Machine learning models, especially LightGBM with ROSE, provide robust and clinically interpretable risk stratification after PVC ablation.
  • These models can be integrated into electronic health records for improved patient management.
  • Further external validation and local threshold optimization are recommended.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
323
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
502
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
380